Schedule 13G ownership disclosure

NEUROCRINE BIOSCIENCES INC COM

Common Stock · CUSIP: 64125C109

Event date: 2025-02-28

Filing-level shares
10,129,687
Percent of class
10.15%
  • The Vanguard Group

    Shares: 10,129,687 · Class: 10.15%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000369
Form type
SCHEDULE 13G/A
Filer
NEUROCRINE BIOSCIENCES INC
CIK
CIK 914475
Filed
Mar 06, 2025
Reporting period
Feb 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub